Human marrow megakaryocyte differentiation: Multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes

Blood

Volumn 104, Issue 9, 2004, Pages 2722-2727

  Tomer, Aaron ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD45 ANTIGEN; CELL DNA; CELL MARKER; FC RECEPTOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN IB; GLYCOPROTEIN IIIA; HLA DR ANTIGEN; IMMUNOGLOBULIN G; VON WILLEBRAND FACTOR;

ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LABELING; CELL SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PLOIDY; PRIORITY JOURNAL; RECEPTOR DENSITY; SENSITIVITY AND SPECIFICITY;

EID: 7244258902     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-02-0769     Document Type: Article

References (29)

1. Burstein SA, Harker LA. Control of platelet production. Clin Haematol. 1983;12:3-22.
2. Gewirtz AM. Human megakaryocytopoiesis. Semin Hematol. 1986;23:27-42.
3. Vainchenker W, Kieffer N. Human megakaryocytopoiesis: in vitro regulation and characterization of megakaryocytic precursor cells by differentiation markers. Blood Rev. 1988;2:102-107.
4. Breton-Gorius J, Vainchenker W. Expression of platelet proteins during the in vitro and in vivo differentiation of megakaryocytes and morphological aspects of their maturation. Semin Hematol. 1986;23:43-67.
5. Schick BP, Schick PK. Megakaryocyte biochemistry. Semin Hematol. 1986;23:68-87.
6. Levine RF. Isolation and characterization of normal human megakaryocytes. Br J Haematol. 1980;45:487-497.
7. Tomer A. Megakaryocytopoiesis, kinetics and platelet radiolabeling. In: Rossi EC, ed. Principles of Transfusion Medicine. 3rd ed. Baltimore, MD: Lippincott Williams & Wilkins; 2002:177-191.
8. Tomer A, Harker LA. Thrombocytopoiesis. In: Anderson KC, Ness PM, eds. Scientific Basis of Transfusion Medicine. Philadelphia, PA: W.B. Saunders Company: 1994:40-58.
9. Tomer A, Harker LA, Burstein SA. Purification of human megakaryocytes by fluorescence-activated cell sorting. Blood. 1987;70:1735-1742.
10. Tomer A, Harker LA, Burstein SA. Flow cytometric analysis of normal human megakaryocytes. Blood. 1988;71:1244-1252.
11. Tomer A, Friese P, Conklin R, et al. Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts. Blood. 1989;74:594-601.
12. Hoffman R. Regulation of megakaryocytopoiesis. Blood. 1989;74:1196-1212.
13. Rabellino EM, Goodwin L, Bussel JB, Levene RB, Nachman RL. Studies of human marrow megakaryocytes. In: Evatt R, Levine RF, Williams N, eds. Megakaryocyte Biology and Precursors: In Vitro Cloning and Cellular Properties. New York, NY: Elsevier-North Holland, 1981:43-55.
14. Nakeff A. Megakaryocytic cells. Bibl Haematol. 1984;48:131-209.
15. Parks DR, Herzenberg LA. Fluorescence-activated cell sorting: theory, experimental optimization, and applications in lymphoid cell biology. Methods Enzymol. 1984;108:197-241.
16. Levine RF, Bunn PA, Hazzard KC, Schlam ML. Flow cytometric analysis of megakaryocyte ploidy: comparison with Feulgen microdensitometry and discovery that 8N is the predominant ploidy class in guinea pig and monkey marrow. Blood. 1980;56:210-217.
17. Nakeff A, Valeriote F, Gray JW, Grabske RJ. Application of flow cytometry and cell sorting to megakaryocytopoiesis. Blood. 1979;53:732-745.
18. Jackson CW, Brown KL, Somerville BC, Lyles SA, Look AT. Two-color flow cytometric measurement of DNA distributions of rat megakaryocytes in unfixed, unfractionated marrow cell suspensions. Blood. 1984;63:768-778.
19. Worthington RE, Nakeff A, Micko S. Flow cytometric analysis of megakaryocyte differentiation. Cytometry. 1984;5:501-508.
20. Tomer A. Effects of anagrelide on megakaryocyte proliferation and maturation in essential thrombocythemia. Blood. 2002;99:1602-1609.
21. Shapiro HM. Practical flow cytometry. 2nd ed. New York, NY: Alan R. Liss; 1988:17-120.
22. Loken MR, Stall AM. Flow cytometry as an analytical tool in immunology. J Immunol Methods. 1982;50:R85-R112.
23. Navarro S, Debili N, LeCouedic J-P, et al. Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. Blood. 1991;77:461-471.
24. Levine RF, Hazzard KC, Lamberg JD. The significance of megakaryocyte size. Blood. 1982;60:1123-1131.
25. Tomer A, Scharf RE, McMillan R, Ruggeri ZM, Harker LA. Bernard-Soulier syndrome: quantitative characterization of megakaryocytes and platelets by flow cytometric and platelet kinetic measurements. Eur J Haematol. 1994;52:193-200.
26. Tomer A, Stahl C, McClure H, et al. Effects of rhGM-CSF on platelet survival and activation using a non-human primate model. Exp Hematol. 1993;21:1577-1582.
27. Corash L, Chen HY, Levin J, Baker C, Lu H, Mok Y. Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume. Blood. 1987;70:177-185.
28. Harker LA, Marzec UM, Kelly AB, et al. Prevention of thrombocytopenia and neutropenia in a non-human model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony stimulating factor. Blood. 1997;89:155-165.
29. Tomer A, Harker LA. Measurements of in vivo megakaryocytopoiesis: studies in nonhuman primates and patients. Stem Cells. 1996;14:18-30.